Skip to main content
. 2021 Jan 18;39(3):803–811. doi: 10.1007/s10637-020-01047-5

Fig. 5.

Fig. 5

Median entrectinib plasma concentration-time profiles of 600 mg entrectinib administered as marketed and research formulations in the fasted state (left panel) and the effect of food on the marketed formulation (right panel)